Connect with us
MDMA became famous in the 80s as a party drug under the names Ecstasy or Molly - complete with abuse, damage, and deaths. As a result,...
AstraZeneca Spain's president, Rick R. Suárez, announced a €1.3 billion investment in Catalonia until 2027, exceeding previous plans by €500 million. They aim to employ 2,000...
BlackRock, Capital Research and Management Company, and Jefferies Financial Group lend over 170 million euros in Grifols shares. Specifically, BlackRock, which has a 4.3% stake in...
Almirall has acquired exclusive rights to Eloxx Pharmaceuticals' ZKN-013, a potentially promising treatment for rare dermatological diseases. Almirall gains global development and commercialization rights, paying Eloxx...
AstraZeneca and Wivi Vision were awarded the Bioèxit Prize during the Nit event organized by CataloniaBio&HealthTech. AstraZeneca was recognized for establishing its global hub in Barcelona,...
In the Spanish biotech sector, 60% of employees are women, yet only 37% of leadership positions in companies are held by women, according to a report...
Braingaze, a digital cognitive health spin-off of the University of Barcelona, successfully closed an investment round, raising €1.5 million. Led by Ryse Asset Management, the funds...
The main European stock markets opened this Wednesday with mixed trends. Specifically, Paris and London lost 0.1% and 0.05%, respectively, while Milan and Frankfurt rose 0.16%...
Grifols' guidance for 2024 estimates recording an adjusted EBITDA of more than 1.8 billion euros, as well as a free cash flow of five million euros....
Of the Spanish pharma listed companies, PharmaMar has suffered the most significant drop in profits due to generic drug competition with its star drug. Rovi has...